BPC-157: evidence brief
What was actually studied
A small uncontrolled knee-pain report and a two-person safety pilot leave human efficacy and longer-term safety unresolved. The selected rat comparison did not show a significant BPC-157 advantage on tendon failure load.
- Version
- 2026-10-05.1
- Snapshot updated
Prepared by Peptides Codex. Independent review by a qualified subject specialist is pending.
Scope of this brief
Selected primary studies of author-labelled BPC-157 preparations. The profile's GEPPPGKPADDAGLV reference does not authenticate the material used in every study. This brief is not a systematic review, a dosing guide or an independent expert review.
Lee & Padgett, 2021 · PMID 34324435
- Material tested
- Author-labelled BPC-157 alone or with TB4; exact batch identity not established here.
- Model or population
- People with different causes of knee pain.
- Study design
- Single-clinic retrospective chart review and telephone follow-up; no control group.
- Sample and comparison
- 17 records; 16 reached: 12 BPC-157 alone, 4 BPC-157 + TB4.
- Reported finding
- Reported improvement: 11/12 with BPC-157 alone and 3/4 with the combination.
- Limits of this evidence
- Self-report, variable follow-up and no validated functional measures. Cannot establish efficacy or added combination benefit.
Source access: Primary abstract and author-hosted full text inspected.
Lee & Burgess, 2025 · PMID 40131143
- Material tested
- Intravenous BPC-157-labelled preparation; exact formulation not characterized in the retrieved abstract.
- Model or population
- Two adults previously exposed to intravenous BPC-157.
- Study design
- Uncontrolled safety pilot; blood tests and vital signs across three days.
- Sample and comparison
- 2 participants.
- Reported finding
- No reported side effects or measurable changes in the tested organ and metabolic biomarkers.
- Limits of this evidence
- No efficacy endpoint. Two prior-exposed people and short observation cannot establish general or long-term safety.
Source access: Primary abstract inspected; publisher full text unavailable during this review.
Biçer et al., 2026 · PMID 42542926
- Material tested
- Authors' BPC-157 preparation; comparator and combination used TB-500-labelled material.
- Model or population
- Male rats after Achilles tendon transection and surgical repair.
- Study design
- Randomized four-arm experiment; assessment at four weeks.
- Sample and comparison
- 32 rats, 8/group; separate biomechanical and histology cohorts of 4/group.
- Reported finding
- BPC-157 failure load was not significantly different from control (adjusted p=0.389). Combination showed no added benefit.
- Limits of this evidence
- Small animal endpoint cohorts; no human efficacy inference. TB-500 sequence was not characterized.
Source access: Primary journal full text and PubMed abstract inspected.
A finding applies to the material, model and conditions studied. It does not establish safety or effectiveness in other settings.
Help review this exact version
Qualified scientific review is pending. Source-backed corrections are welcome; a correction submission does not itself constitute expert approval.
Review reference: bpc-157 · 2026-10-05.1
What a reviewer should check
- Does the reported material match the preparation actually studied?
- Do population, participant counts and analysis denominators match the source?
- Are estimates, endpoints, uncertainty and missing-data methods represented accurately?
- Do limitations, source-access boundaries and English/French text preserve the same conclusion?
Study records in this version
In your message, include this brief reference, the study identifier, the source citation and the proposed change. If offering scientific review, include your relevant specialty and conflicts of interest. Omit patient information and confidential research material.
Recording a qualified review requires verified qualifications, an agreed scope and approval of the identified version. Public reviewer attribution requires separate permission. Review status remains pending until that process is complete.
Send source-backed feedback →To save this brief as a PDF, use your browser’s Print command and choose Save as PDF. The study details and source URLs are included in the print layout.